Illumina Inc. (ILMN)

374.60
11.00 3.00
NASDAQ : Health Technology
Prev Close 363.82
Day Low/High 360.01 / 377.80
52 Wk Low/High 196.78 / 380.76
Avg Volume 1.36M
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 52.10B
EPS 6.80
P/E Ratio 57.38
Div & Yield N.A. (N.A)
Does Illumina Have the Genes for Lasting Growth?

Does Illumina Have the Genes for Lasting Growth?

This week's introduction of the NovaSeq Series of genomic sequencers caused the stock to jump.

Illumina: The Bears Have Taken Control

Illumina: The Bears Have Taken Control

Considering the major top formation, don't get in their way.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Technology stocks dominate the bearish ledger this week.

Trader's Daily Notebook: You Might Consider Selling Facebook

Trader's Daily Notebook: You Might Consider Selling Facebook

Do that if you like top ticking crowd favorites, but set a protective stop.

Avoid Twitter Like the Plague; It's Uninvestable

Avoid Twitter Like the Plague; It's Uninvestable

If Twitter puts up a dreadful quarter, shares will sell off again.

My Takeaways and Observations

The media is not the message. With a little help from Johnny Mercer, did you know he founded Capitol Records?   This is serious folks -- I see less of a reason to have an outsized long portfolio than at any time since Winter 2007. The market outlook...

Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide

Cramer: Sing It, Martha -- Nowhere to Run to in This Market, Nowhere to Hide

On days like this, the money just keeps sloshing around.

Midday Report: Yum! Brands Climbs on Franchise Plan; U.S. Stocks Slide

Midday Report: Yum! Brands Climbs on Franchise Plan; U.S. Stocks Slide

U.S. stocks slipped after a disappointing quarterly performance from Alcoa soured optimism over earnings season.

Illumina Shares Hammered by Sales Forecast Cut

Illumina Shares Hammered by Sales Forecast Cut

Cantor Fitzgerald says Illumina's outlook revision is not likely to affect industry peers.

Morning Movers: ILMN, STJ, AA, MRO, CHK

Morning Movers: ILMN, STJ, AA, MRO, CHK

Shares of Illumina were tanking before the opening bell after unveiling a disappointing sales forecast.

Illumina downgraded at Citi

Back in the Saddle With Some Brief Takeaways

Back from my meetings to find the S&P 500 Index basically traded in a 2-3 point range over the last four hours, which is a statistically improbable event!   Highs were made early in the day when I issued my Trade of the Week (short SPDR S&P 500 ETF ...

Illumina Faces a Bumpy Ride for a Few Quarters

Illumina Faces a Bumpy Ride for a Few Quarters

I have been a big bull on its technology, but I am sidelined right now.

Bullish and Bearish Reversals for the Week

Bullish and Bearish Reversals for the Week

Lots of energy names facing the potential for lower prices.

Illumina downgraded at Morgan Stanley

Illumina downgraded at BofA/Merrill

Illumina downgraded at Cantor

Illumina Lights Up in Radiant Rally

Illumina Lights Up in Radiant Rally

Following the positive action over the last four days, an upside resolution now appears likely. 

Illumina downgraded at Canaccord

Illumina downgraded at Wells

This Laggard Is Set to Shine

This Laggard Is Set to Shine

Illumina is moving toward higher ground.

Illumina's Future Looks Very Bright

Illumina's Future Looks Very Bright

Charts show ILMN is close to offering a great profit opportunity.

Novice Trade: Illumina

Novice Trade: Illumina

ILMN's three-month at-the-money implied volatility is at about the median level.

Illumina Could Light Up; a Reversal Is in the Works

Illumina Could Light Up; a Reversal Is in the Works

With very low oversold readings and a possible reversal pattern, we would at least cover shorts, and would consider probing the long side.

Today's Takeaways and Observations (Monarch Notes Edition --- Because I Am Beat).

My thoughts on the day: The five-day market win streak stalled a bit today. Though the close was weak, I still give the win to the bulls because of the modest drop in the averages after an 80-handle rise in the S&P index. That said, there was less t...

Are Drug Stocks What's Ailing the Market?

Are Drug Stocks What's Ailing the Market?

This move in health care takes your breath away.

Jared Woodard Intermediate Trade: IBB

Jared Woodard Intermediate Trade: IBB

Take advantage of elevated option premiums to gain long exposure to biotech.

Illumina Plummets on Weak Sales Forecast; Biotech Stocks Fall

Illumina Plummets on Weak Sales Forecast; Biotech Stocks Fall

DNA sequencing company Illumina (ILMN) plummeted in midday trading Tuesday after reporting disappointing preliminary sales for its third quarter.

Illumina Dims, but It's Still Set Up to Shine

With such a commanding lead in the sequencing business the stock can't stay down for long.